Cargando…

Cell entry mechanisms of SARS-CoV-2

A novel severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2) is causing the global coronavirus disease 2019 (COVID-19) pandemic. Understanding how SARS-CoV-2 enters human cells is a high priority for deciphering its mystery and curbing its spread. A virus surface spike protein medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Jian, Wan, Yushun, Luo, Chuming, Ye, Gang, Geng, Qibin, Auerbach, Ashley, Li, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2020
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260975/ https://www.ncbi.nlm.nih.gov/pubmed/32376634 http://dx.doi.org/10.1073/pnas.2003138117

Ejemplares similares

Structural basis of receptor recognition by SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein
por: Geng, Qibin, et al.
Publicado: (2023)

Targeting spike glycans to inhibit SARS-CoV2 viral entry
por: Guseman, Alex J., et al.
Publicado: (2023)

SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry
por: Yang, Bo, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
por: Qiao, Yuanyuan, et al.
Publicado: (2021)

Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells
por: Amraei, Razie, et al.
Publicado: (2022)

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry
por: Valero, Julián, et al.
Publicado: (2021)

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
por: Mahoney, Matthew, et al.
Publicado: (2021)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
por: Sanders, David W, et al.
Publicado: (2021)

Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein
por: Wan, Yushun, et al.
Publicado: (2021)

Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry
por: Shang, Jian, et al.
Publicado: (2020)

Inhalable nanocatchers for SARS-CoV-2 inhibition
por: Zhang, Han, et al.
Publicado: (2021)

An extended conformation of SARS-CoV-2 main protease reveals allosteric targets
por: Sun, Zengchao, et al.
Publicado: (2022)

Intermediates in SARS-CoV-2 spike–mediated cell entry
por: Marcink, Tara C., et al.
Publicado: (2022)

Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants
por: Li, Cun, et al.
Publicado: (2023)

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
por: Wan, Yushun, et al.
Publicado: (2020)

ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
por: Zamorano Cuervo, Natalia, et al.
Publicado: (2020)

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
por: Ye, Gang, et al.
Publicado: (2021)

Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1
por: Geng, Qibin, et al.
Publicado: (2022)

Bepridil is potent against SARS-CoV-2 in vitro
por: Vatansever, Erol C., et al.
Publicado: (2021)

The origin and early spread of SARS-CoV-2 in Europe
por: Nadeau, Sarah A., et al.
Publicado: (2021)

The total number and mass of SARS-CoV-2 virions
por: Sender, Ron, et al.
Publicado: (2021)

Targeted vaccination and the speed of SARS-CoV-2 adaptation
por: Gandon, Sylvain, et al.
Publicado: (2022)

Tropism of SARS-CoV-2 for human cortical astrocytes
por: Andrews, Madeline G., et al.
Publicado: (2022)

Interferon resistance of emerging SARS-CoV-2 variants
por: Guo, Kejun, et al.
Publicado: (2022)

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2
por: Muñoz-Basagoiti, Jordana, et al.
Publicado: (2023)

Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2–encoded Nsp1
por: Wang, Xingjun, et al.
Publicado: (2022)

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
por: Jan, Jia-Tsrong, et al.
Publicado: (2021)

Estimating unobserved SARS-CoV-2 infections in the United States
por: Perkins, T. Alex, et al.
Publicado: (2020)

Ongoing global and regional adaptive evolution of SARS-CoV-2
por: Rochman, Nash D., et al.
Publicado: (2021)

SARS-CoV-2 spreads through cell-to-cell transmission
por: Zeng, Cong, et al.
Publicado: (2021)

SARS-CoV-2 evolution influences GBP and IFITM sensitivity
por: Mesner, Dejan, et al.
Publicado: (2023)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
por: Shan, Sisi, et al.
Publicado: (2022)

Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
por: Kastenhuber, Edward R, et al.
Publicado: (2022)

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
por: Ye, Chengjin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5p8fb6vbd0b3bhe5t67rm99gc